Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 95   

Articles published

THRX 16.94 +0.04 (0.24%)
price chart
Stock Runners: Weatherford International plc (NYSE:WFT), Theravance Inc ...
Theravance Inc. (NASDAQ:THRX) shares increased 1.68% in last trading session and ended the day at $16.90. THRX return on assets is -20.60%.
Theravance (THRX) Passes Through 6% Yield Mark
Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Theravance Inc (NASD: THRX) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.00), with the stock changing hands as low as ...
Billionaire Klarman's Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF ...
The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman. Klarman's fund is one of the biggest and most successful hedge fund firms in the world, ranking fourth in net gains since its founding, according to ...
Theravance Inc.: Theravance Biopharma and SciClone Pharmaceuticals Enter ...
GEORGE TOWN, GRAND CAYMAN and FOSTER CITY, CA -- (Marketwired) -- 05/27/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma"), through an affiliate, and SciClone Pharmaceuticals (NASDAQ: SCLN) ("SciClone"), ...
Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development ...  MarketWatch
Volatile Theravance Inc. Offers Attractive Total Returns Potential (THRX)
Theravance, Inc. is a royalty management company. The South San Francisco, California-headquartered company is primarily focused on maximizing the potential value of the respiratory assets partnered with United Kingdom-based pharmaceutical giant ...
Stock in Motion: Theravance, Inc. (NASDAQ:THRX)
Theravance, Inc. (NASDAQ:THRX) shares opened the most recent trading session at 16.93 and at the time of writing the last Bid was at 16.77.
Theravance Inc.: Theravance Biopharma, Inc. Reports First Quarter 2015 ...
GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 05/07/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the first quarter ending March 31, 2015. Revenue for the first ...
Theravance Biopharma, Inc. Reports First Quarter 2015 Financial Results  MarketWatch
Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2015 Results ...  Seeking Alpha
Analyst Perspectives on Theravance, Inc. (NASDAQ:THRX)
Based on analyst estimates, Theravance, Inc. (NASDAQ:THRX) is expected to post current fiscal quarter earnings per share of $-0.06.
Theravance Inc (THRX) is Trading Lower on Unusual Volume for May 06
Theravance Inc (THRX) experienced unusually high volume on May. 06, as the stock lost 6.27% to a closing price of $15.56. The stock saw 1.29 million shares trade hands over the course of the day on 10,034 trades.
Q4 Earnings of $-0.08 Anticipated for Theravance, Inc. (NASDAQ:THRX)
Wall Street analysts expect Theravance, Inc. (NASDAQ:THRX) to report earnings per share of $-0.08 for the current fiscal quarter.